Literature DB >> 2192444

Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis.

A C Kinn1, P O Larsson.   

Abstract

Thirteen patients with advanced multiple sclerosis and urge urinary incontinence were treated with desmopressin--a synthetic analogue of antidiuretic hormone--in a double-blind cross-over study. The micturition frequency decreased significantly (p less than 0.05). Less leakage was considered valuable for daily life. Peroral medication was favourable in these patients with muscular dysfunction. Side-effects were few.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192444     DOI: 10.3109/00365599009180373

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  6 in total

1.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

2.  [Not Available].

Authors:  E Schick; J Tessier
Journal:  Can Fam Physician       Date:  1991-05       Impact factor: 3.275

3.  Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories.

Authors:  Noori S Al-Waili; Thia N Al-Waili; Ali N Al-Waili; Khelod Y Saloom
Journal:  World J Urol       Date:  2005-09-27       Impact factor: 4.226

4.  Autonomic Nervous System Dysfunction in Parkinson's Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Mervat Wahba; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

5.  Bladder, Bowel, and Sexual Dysfunction in Multiple Sclerosis.

Authors:  Kathleen S. Hawker; Elliot M. Frohman
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

6.  Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia.

Authors:  Athanasios Zahariou; Maria Karamouti; George Karagiannis; Polyanthi Papaioannou
Journal:  Int Urol Nephrol       Date:  2007-07-03       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.